Finally, the cited work considered that different expression of FPR1 might be attributed to differences in exposure to luminal formyl peptides, while in the present study both luminal formyl peptides and proinflammatory factors might affect the expression of FPR1 in a cancer environment. This evidence concerns the gene FPR1 and cancer.